导师资格：博士生导师

所在教研室/单位： 病理生理学教研室

E-mail：[email protected]

研究方向：本实验室致力于研究造血干细胞和免疫细胞微环境，之前工作发表在在Nature、Nature Medicine 、Immunity 、Cell Stem Cell, Nature Communications 、Journal of Experimental Medicine 和Blood 等国际学术期刊，累计发表论文30余篇，被引用4700余次。主要学术贡献如下：1) 精神压力通过肠道菌群促进血管炎症和疾病的发生 (Immunity, 2020); 2) 疼痛神经通过 CGRP 抑制炎症反应 (JEM, 2021); 3) 环境因素促进血管炎症和疾病的发生 (Nature Medicine, 2018); 4) 骨髓动脉血管通过分泌干细胞因子调控造血干细胞的维持和再生 (Nature Communications, 2018)

个人简介

徐春亮，博彩公司排名-博彩公司评级 教授，博士生导师，中组部“海外高层次人才”青年项目获得者，中山大学“百人计划”引进人才。

教育经历

2003-2007 山东大学，生物技术基地班，理学学士；

2007-2013 中科院上海生命科学研究院/上海交通大学医学院健康科学研究所，细胞生物学博士学位，导师：时玉舫教授

工作经历

2013-2014 哥伦比亚大学，博士后，合作导师： Remi Creusot

2014-2018 爱因斯坦医学院, 博士后，合作导师：Paul Frenette

2018-2021 爱因斯坦医学院, 副研究员（Associate），合作导师：Paul Frenette

2021-2022 香港中文大学, 博士生导师、独立PI

2022-至今 博彩公司排名-博彩公司评级 ，教授

研究方向

本实验室致力于研究造血干细胞和免疫细胞微环境，之前工作发表在在Nature、Nature Medicine 、Immunity 、Cell Stem Cell, Nature Communications 、Journal of Experimental Medicine 和Blood 等国际学术期刊，累计发表论文30余篇，被引用4700余次。主要学术贡献如下：1) 精神压力通过肠道菌群促进血管炎症和疾病的发生 (Immunity, 2020); 2) 疼痛神经通过 CGRP 抑制炎症反应 (JEM, 2021); 3) 环境因素促进血管炎症和疾病的发生 (Nature Medicine, 2018); 4) 骨髓动脉血管通过分泌干细胞因子调控造血干细胞的维持和再生 (Nature Communications, 2018) 。

发表论文

  1. Xu C, Lee SK, Zhang D, Frenette PS. The gut microbiome regulates psychological stress-induced inflammation. Immunity, 2020 Aug 18;53(2):417-428.e4.

        Highlighted by Nature: Gut microbes and stress team up to make a painful disease worse.

        Preview in Immunity: Gut Feelings Block the Flow: Microbiota Links Stress to Vascular Disease.

        Highlighted by Science Translational Medicine: A gut feeling to stress enhances neutrophil-mediated vascular occlusion.

  1. Xu C, Frenette PS. Seasonal manifestations of sickle cell disease. Nature Medicine. 2019 Apr;25(4):536-537.
  2. Xu C, Gao X, Wei Q, Nakahara F, Zimmerman SE, Mar J, Frenette PS. Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow. Nature Communications. 2018 Jun;9(1):2449.
  3. Xu C, Gulinello M, Frenette PS. Nociceptors protect sickle cell disease mice from vaso-occlusive episodes and chronic organ damage. Journal of Experimental Medicine, 2021. 218 (1): e20200065. Highlighted by Science Translational Medicine: A spicy solution for sickle cell disease.
  4. Zhang D*, Xu C*, Manwani D*, Frenette PS. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016 Feb;127(7):801-9. (* equal contribution).  
  5. Gao X, Zhang D*, Xu C*, Li H, Caron KM, Frenette PS. Nociceptive nerves regulate haematopoietic stem cell mobilization. Nature. 2021 Jan;589(7843):591-596. (*Equal contribution).
  6. Xu C, Lin L, Cao G, Chen Q, Shou P, Huang Y, Han Y, Wang Y, Shi Y. IFNα-secreting MSCs exerts potent anti-tumor effect in vivo. Oncogene. 2014 Oct;33(42):5047-52.
  7. Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith J, Burk R, Kunisaki Y, Jang J, Scheiermann C, Merad M, Frenette PS. Neutrophil ageing is regulated by the microbiome. Nature. 2015 Sep;525(7570):528-32.
  8. Poller WC, Downey J, Mooslechner AA, Khan N, Li L, Chan CT, McAlpine CS, Xu C, Kahles F, He S, Janssen H, Mindur JE, Singh S, Kiss MG, Alonso-Herranz L, Iwamoto Y, Kohler RH, Wong LP, Chetal K, Russo SJ, Sadreyev RI, Weissleder R, Nahrendorf M, Frenette PS, Divangahi M, Swirski FK. Brain motor and fear circuits regulate leukocytes during acute stress. Nature. 2022 May. Online ahead of print.
  9. Zhang D, Gao X, Li H, Borger DK, Wei Q, Yang E, Xu C, Pinho S, Frenette PS. The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow. Cell Stem Cell. 2022 Feb 3;29(2):232-247.
  10. Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, Yuan ZR, Roberts AI, Zhang L, Zheng B, Wen T, Han Y, Rabson AB, Tischfield JA, Shao C, Shi Y. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell. 2012 Dec;11(6):812-24.
  11. Nakahara F, Borger DK, Wei Q, Pinho S, Maryanovich M, Zahalka A, Suzuki M, Cruz CD, Wang Z, Xu C, Boulais PE, Ma'ayan A, Greally J, Frenette PS. Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells. Nature Cell Biology. 2019 May;21(5):560-567.
  12. Zheng C, Yang Q, Xu C, Shou P, Cao J, Jiang M, Chen Q, Cao Q, Han Y, Li F, Cao W, Zhang L, Zhang L, Shi Y, Wang Y. CD11b Regulates obesity-induced insulin resistance via limiting alternative Activation and proliferation of adipose tissue macrophages. Proceedings of the National Academy of Sciences of the United States of America. 2015 Dec;112(52):E7239-48.
  13. Xu C, Yu P, Han X, Du L, Gan J, Wang Y, Shi Y. Transforming growth factor β promotes immune responses in the presence of mesenchymal stem cells. The Journal of Immunology. 2014 Jan;192(1):103-9. (Highlighted in the “In This Issue” section).
  14. Xu C, Ren G, Cao G, Chen Q and Shou P, Zheng C, Du L, Han X, Jiang M, Yang Q, Lin L, Wang G, Yu P, Zhang X, Cao W, Brewer G, Wang Y, Shi Y. miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2. The Journal of Biological Chemistry. 2013 Apr;288(16):11074-9.
  15. Zhang T, Wang Y, Li Q, Lin L, Xu C, Xue Y, Hu M, Shi Y, Wang Y. Mesenchymal stromal cells equipped by IFNα empower T cells with potent anti-tumor immunity. Oncogene. 2022 Mar;41(13):1866-1881.
  16. Wei Q, Nakahara F, Asada N, Zhang D, Gao Xin, Xu C, Alfieri A, Brodin NP, Zimmerman SE, Mar JC, Guha C, Guo W, and Frenette PS. Snai2 Maintains Bone Marrow Niche Cells by Repressing Osteopontin Expression. Developmental Cell. 2020 Jun 8;53(5):503-513.e5.
  17. Wei Q, Pinho S, Dong S, Pierce H, Li H, Nakahara F, Xu J, Xu C, Boulais PE, Zhang D, Maryanovich M, Cuervo AM and Frenette PS. MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells. Nature Communications volume 12, Article number: 2522 (2021).
  18. Gonzalez CD, Ledo C, Cela E, Stella I, Xu C, Ojeda DS, Frenette PS, Gomez M. The good side of inflammation: Staphylococcus aureus proteins SpA and Sbi contribute to proper abscess formation and wound healing during skin and soft tissue infections. BBA-Molecular Basis of Disease. 2019 Oct;1865(10):2657-2670.
  19. Gao X, Xu C, Asada N, Frenette PS. The hematopoietic stem cell niche: from embryo to adult. Development. 2018 Jan;145(2).
  20. Dastagir SD*, Postigo-Fernandez J*, Xu C, Stoeckle J, Firdessa-Fite R, Creusot RJ. Efficient presentation of multiple endogenous epitopes to both CD4+ and CD8+ diabetogenic T cells for tolerance. Molecular Therapy-Methods & Clinical Development. 2016 Dec;4:27-38. (* equal contribution).
  21. Yu P, Huang Y, Xu C, Lin L, Han Y, Sun W, Hu G, Rabson AB, Wang Y, Shi Y. Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis. Oncogene. 2017 Feb;36(6):840-849.
  22. Shou P, Chen Q, Jiang J, Xu C, Zhang J, Zheng C, Jiang M, Velletri T, Cao W, Huang Y, Yang Q, Han X, Zhang L, Wei L, Rabson AB, Chin YE, Wang Y, Shi Y. Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells. Oncogene. 2016 Nov;35(46):5953-5962.
  23. Jiang M, Zheng C, Shou P, Li N, Cao G, Chen Q, Xu C, Du L, Yang Q, Cao J, Han Y, Li F, Cao W, Liu F, Rabson AB, Roberts AI, Xie W, Wang Y, Shi Y. SHP1 regulates bone mass by directing mesenchymal stem cell differentiation. Cell Report. 2016 Jul;16(3):769-80.
  24. Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q, Cao J, Xie N, Velletri T, Zhang X, Xu C, Zhang L, Yang H, Hou J, Wang Y, Shi Y. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differentiation. 2016 Jul;23(7):1128-39.
  25. Han X, Yang Q, Lin L, Xu C, Zheng C, Chen X, Han Y, Li M, Cao W, Chen Q, Xu G, Zhang Y, Schneider R, Qian Y, Wang Y, Brewer G, Shi Y. Interleukin-17A enhances immunosuppression by mesenchymal stem cells. Cell Death and Differentiation. 2014 Nov;21(11):1758-68.
  26. Zhu K, Zhang N, Guo N, Yang J, Wang J, Yang C, Yang C, Zhu L, Xu C, Deng Q, Zhu R, Wang H, Chen X, Shi Y, Li Y, Leng Q. SSChighCD11bhighLy-6ChighLy-6Glow myeloid cells curtail CD4 T cell response by inducing nitric oxide synthase in murine hepatitis. The International Journal of Biochemistry & Cell Biology. 2014 Sep;54:89-97.
  27. Huang Y, Yu P, Li W, Ren G, Roberts A, Cao C, Zhang X, Su J, Chen X, Chen Q, Shou P, Xu C, Du L, Lin L, Xie N, Zhang L, Wang Y, Shi Y. p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation. Oncogene. 2014 Jul;33(29):3830-8.
  28. Cao G, Yang Q, Zhang S, Xu C, Wang Y, Shi Y. Mesenchymal stem cells prevent restraint stress-induced lymphocyte reduction via Interleukin-4. Brain, Behavior, and Immunity. 2014 May;38:125-32.
  29. Chen Q, Shou P, Zhang L, Xu C, Zheng C, Han Y, Li W, Huang Y, Zhang X, Shao C, Roberts, A, Robson A, Ren G, Zhang Y, Wang Y, Denhardt D, Shi Y. An osteopontin-Integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells. Stem Cells. 2014 Feb;32(2):327-37.
  30. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, Xu C, Chen X, Huang Y, Zhu Z, Huang X, Han X, Xie N, Ren G. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Research. 2010 May;20(5):510-8.
  31. Tao W, Xu C, Ding Q, Li R, Xiang Y, Chung J, Zhong J. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles. Virology. 2009 Dec;395(1):67-76.
  32. Wang H, Xu C, Cai F, Cao J, Chen X, Wu F. The research of the relationship between cyclooxygenase-2 and monocyte endothelial cells adhesion. Chinese Journal of Laboratory Diagnosis. 2013 Nov; 17(10).
  33. Manwani D, Xu C, Lee SK, Amatuni G, Cohen H, Carullo V, Morrone K, Davila J, Shi PA, Ireland K, Keenan J, Frenette PS. Randomized Phase 2 trial of Intravenous Gamma Globulin (IVIG) for the Treatment of Acute Vaso-Occlusive Crisis in Patients with Sickle Cell disease: Lessons Learned from the Midpoint Analysis. Complementary Therapies in Medicine, 2020 Aug; Volume 52, 102481.

科研项目

主要承担课题及人才项目

  1. 中组部，海外高层次人才青年项目，2023-2025，在研，主持；
  2. 国家自然科学基金委员会, 重大研究计划培育项目, 2022-2024, 在研, 主持；
  3. 国家自然科学基金委员会, 面上项目，2023-2026, 在研, 主持；
  4. 科技部，国家重点研发计划项目，MSC治疗移植物抗宿主病等重大疾病的监管和评价的技术体系研究，2022-2027, 在研，骨干 ；
  5. 科技部，国家重点研发计划项目，间充质干细胞在组织稳态维持与疾病发生中的作用机制及靶向干预治疗研究，2022-2027,在研，骨干；
  6. 广东省科学技术厅，广东省自然科学基金面上项目，2023-2026，主持
  7. 中山大学，百人计划中青年杰出人才项目，2022-2024，在研，主持；
  8. 中山大学，高校基本科研业务费-青年教师培育项目，2023-2023，在研，主持。